Oct 27, 2021 | Updated: 07:19 PM EDT

Glooko App for Android Review

Nov 07, 2013 12:35 PM EST

Glooko’s Diabetes Management System App for Android is innovative. The Android Compatible System was cleared by the FDA and launched this past October. The Glooko App is also available for download in Google Play Store. Glooko, Inc. creates mobile solutions for diabetes management. Glooko is an Android version from its next generation Glooko Diabetes Management System.  

Diabetes rates within the U.S. are staggering. According to American Diabetes Association, nearly 19 million Americans — or more than 8 percent of the population — have diabetes. An estimated 7 million more are living with diabetes and have no idea they have it. Providing mobile access to devices with assist with managing diabetes.

The Glooko Android app consists of MeterSync Cable and web dashboards. The app is the only FDA-cleared mobile diabetes management system. The system was designed to support and transfer blood glucose data directly from up to dozens of glucose meters for Android devices.

"Our diabetes management system aims for universal access for people with diabetes across the globe," stated Rick Altinger, Glooko CEO. "By leveraging Android's market reach, we hope that providers, health systems and payers can efficiently manage their diabetes patients, improve outcomes and lower costs."

The company had also partnered with Samsung Enterprise Alliance Program (SEAP). Glooko's Android app also can be integrated with Glooko Diabetes Management web dashboards. The dashboards enable healthcare professionals to conduct blood glucose level analysis, search for at-risk patients and improve decision making.

2013 has presented significant mobile technology opportunities for digital health innovation and consumerization. Glooko’s mobile apps focus on healthcare personalization of the professionals experiences through the Android dashboard app approach. The company will leverage apps and digital tools that support professionals.

eMarketer estimates that digital pharma U.S. ad spending will reach $1.19 billion in 2013 and climb to $1.33 billion by 2016. 2012 marked a year of many opportunities in digital health enjoying high growth rates over the past twelve months. Digital health investments for software rose 19 percent and digital health grew 45 percent. Personal health tools and health tracking totaled $143 million. Consumer engagement was at $237 million. The market has also remained cautious in its investment strategies following regulations and standards.

Android’s mobile operating system support will give the company a powerful diabetes management platform. This platform is accessible to millions of people living with diabetes. The app is compatible with Android devices Samsung Galaxy SIII and S4. Android users can download the glucose data app from compatible meters and Google Play. The company released the current meters available as Roche's ACCU-CHEK(R) Aviva (Black), Abbott's FreeStyle Lite(R), and Lifescan's OneTouch(R) Ultra(R)2, OneTouch(R) UltraLink(R), and a variety of Nipro meters. 

Real Time Analytics